Aurinia Pharmaceuticals has announced top line results from a Phase IIb clinical study of volclosporin for the treatment of lupus nephritis.
A patient tool to help you better organize your prescription information.
Research!America has chosen the Foundation as the recipient of the Paul G. Rogers Distinguished Organization Advocacy Award.
The Pharmaceutical Research and Manufacturers of America's Medicines in Development Report cites 39 medicines in development for lupus.
Check out our featured "CHAMPION of the Week" for The Cleveland Walk to End Lupus Now!
Legislation to address step therapy requirements is close to being signed by the Governor in New York.Similar legislation is underway in Ohio.